Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.71
-0.17 (-0.59%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
How To Earn $500 Per Month From Pfizer Stock
January 23, 2024
Via
Benzinga
Bristol Myers Squibb's Combo Therapy Shows Sustained Benefits Over Pfizer's Cancer Drug In Kidney Cancer Patients After 8 Years Of Followup
January 23, 2024
Bristol Myer's Opdivo/Yervoy's long-term survival benefits in CheckMate-214 trial for advanced renal cell carcinoma. Significant reductions in risk of death, improved OS, PFS, and ORR after eight...
Via
Benzinga
Competitor Analysis: Evaluating Pfizer And Competitors In Pharmaceuticals Industry
January 22, 2024
Via
Benzinga
Wednesday Is Your Last Chance To Buy Pfizer Before The Dividend Payout
January 22, 2024
Via
Benzinga
3 Ultra-High-Yield Dividend Stocks That Are Simply Too Cheap to Ignore
January 22, 2024
These stocks check off all the boxes for income and value investors.
Via
The Motley Fool
2 Incredible Growth Stocks That Are Screaming Buys for 2024
January 22, 2024
These healthcare businesses are compelling buys for very different reasons.
Via
The Motley Fool
Is Lilly Getting Silly?
January 18, 2024
An old-school drug company, Eli Lilly (LLY), has worked its way into the
Via
Talk Markets
Check Out What Whales Are Doing With PFE
January 18, 2024
Via
Benzinga
Why Pfizer Stock Is a Fantastic Pharma Comeback Candidate
January 17, 2024
If Pfizer can seize a piece of the obesity-drug pie, PFE stock has the potential to rebound sharply this year.
Via
InvestorPlace
4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either
January 20, 2024
These stocks never seem to go on sale. Here's why I'm buying them anyway.
Via
The Motley Fool
Better Bull Market Buy: Pfizer vs. Moderna
January 20, 2024
There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks.
Via
The Motley Fool
Exposures
COVID-19
Ex-Pfizer Employee Netted $270,000 In Illicit Profits Tied To Paxlovid Results
January 19, 2024
A jury found the former senior statistical lead guilty of securities fraud and conspiracy to commit securities fraud.
Via
Investor's Business Daily
Topics
Fraud
Exposures
Legal
Pfizer, Autodesk, AbbVie And More: CNBC's 'Final Trades'
January 19, 2024
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund (NYSE: XLV)
Via
Benzinga
Pfizer Insider Trading: Former Employee Found Guilty Of Trading On Successful COVID-19 Paxlovid Trial News
January 19, 2024
Amit Dagar, ex-Pfizer lead, guilty of securities fraud for insider trading on COVID drug trial info.
Via
Benzinga
Topics
Fraud
Exposures
COVID-19
Legal
Is Pfizer Stock a Buy in 2024?
January 14, 2024
The drugmaker appears to be a top value play, but execution will be key.
Via
The Motley Fool
7 Incredible Reasons to Buy Pfizer Stock Right Now
January 13, 2024
The company's work should pay off eventually.
Via
The Motley Fool
2 Red Flags That Could Sink Pfizer in 2024
January 13, 2024
Pfizer shares dropped more than 40% last year.
Via
The Motley Fool
3 No-Brainer Stocks to Buy Right Now for Less than $50
January 19, 2024
A little upfront money can go a long way with these three stocks.
Via
The Motley Fool
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
January 18, 2024
These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.
Via
InvestorPlace
Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering?
January 18, 2024
Pharmaceuticals prices are already up in 2024: Can inflation-beating hikes be justified?
Via
Benzinga
Anthropic's Claude Chatbot Gets an Upgrade with Image Analysis, Challenging Google and OpenAI
January 17, 2024
Anthropic's Chatbot Claude Set to Analyze Images, Rivaling Google Bard and ChatGPT. This new feature in Claude could elevate user interaction, offering tasks like image comparison and artwork...
Via
Benzinga
GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
January 17, 2024
GSK sells 300M shares in Haleon at £326/share, raising £978M. GSK to retain 4.2% stake.
Via
Benzinga
Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units
January 16, 2024
On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO) units.
Via
Benzinga
Topics
ETFs
10 Health Care Stocks With Whale Alerts In Today's Session
January 16, 2024
Via
Benzinga
10 High-Yield Dividend Stocks for Huge Amounts of Income
January 16, 2024
All 10 of these dividend stocks have yields above 4%.
Via
The Motley Fool
Financial Relief For Medicare Patients: Part D Overhaul Caps Out-of-Pocket Drug Cost Limits
January 16, 2024
In 2024, the Inflation Reduction Act limits out-of-pocket drug costs to $3,300 annually, with further reductions to $2,000 in 2025.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Infosys Stock Shows Market Leadership; Shares Jumped Recently
January 16, 2024
A Relative Strength Rating upgrade for Infosys stock shows improving technical performance.
Via
Investor's Business Daily
Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold
January 15, 2024
Be sure to sell these meme stocks as they represent fundamentally weak businesses that will continue to erode in value.
Via
InvestorPlace
I'm Passing on Pfizer Stock in 2024. Here's Why.
January 15, 2024
Pfizer's best days might be behind it as demand for its COVID-19 products hits a wall.
Via
The Motley Fool
Exposures
COVID-19
Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends
January 14, 2024
Here are seven overlooked high-yield dividend stocks for you to consider no matter where interest rates at the end of 2024.
Via
InvestorPlace
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.